2020 ACCP Webinar April | Tips and Tricks for Effective Presentations-On Demand
ACCP 2020 Webinar - Tips and Tricks for Effective Presentations - On Demand
Live webinar: April 21, 2020
On-demand webinar recording: April 21, 2020 to April 21, 2023
Why is this article important to your practice?
Scientific discourse is driven by the active dissemination of research and knowledge at all stages of a career. One of the most common ways to communicate scientific findings is to present them at meetings, among peers or to the wider community and to discuss the findings to advance both one’s personal understanding and that of the audience. Preparing a clear message to convey the findings of research, placing them in context without overwhelming the audience and providing a confident conclusion that helps to drive scientific innovation are components of a good presentation. This webinar combines tips & tricks on how to create and format a presentation to provide a consistent message and flow, as well as build on existing skills to further engage and drive the audience to get the message across. A successful presentation is an essential driver for scientific success, networking and a career in all areas of clinical pharmacology.
Inter-professional team of Physicians, Pharmacists, PhDs, Nurse Practitioners, Physician Assistants and Students.
After completing this activity, the learner will be able to:
- State the importance of clear and legible slides as part of a good oral presentation;
- Structure slide presentations in a logical and clear manner, in order to tell the scientific “story”;
- Use titles, figures and tables appropriately in slide presentations;
- Engage and develop good presentation skills and behaviors.
To receive credit, learners must attend the complete live webinar or view the complete on-demand webinar; complete a post-course assessment and evaluation.
Michael Fossler, PharmD, PhD
Vice-President, Clinical Development and Quantitative Sciences
Dr. Fossler is Vice-President, Clinical Development and Quantitative Sciences, at Trevena, Inc. He received the Pharm. D. (1992) and PhD (1995) degrees from the Univ of Maryland. From 1995 to 2000, Dr. Fossler was employed by the FDA as a clinical pharmacology reviewer in the Division of Metabolic and Endocrine Drug Products. In 1998, he was promoted to Senior Reviewer, and joined the Pharmacometrics group at FDA, where he was responsible for reviewing and performing population PK/PD analyses. He left the Agency in 2000 and joined the Clinical Pharmacokinetics Group at DuPont Pharmaceuticals, where he had major responsibility for PK/PD analyses in the cardiovascular and anti-inflammatory areas. In November, 2001, he joined GlaxoSmithKline (GSK), where he continued to work in the cardiovascular area and eventually headed a group of nine pharmacometrics scientists. He left GSK in 2015 to assume his present role at Trevena, Inc, where he heads up clinical pharmacology, clinical operations, biostatistics, programming and data management. Dr. Fossler is a Fellow of the American Foundation for Pharmaceutical Education, a Fellow of the American College of Clinical Pharmacology, a past President of the College and is an Honorary Regent. He holds adjunct faculty appointments at the Univ of Maryland School of Pharmacy, Mercer Univ and the Univ of North Texas, and is on the faculty of the Univ of California’s American Course on Drug Development & Regulatory Science.
Lorraine Rusch, PhD
Vice President, Scientific Strategy & Commercial Development
Dr. Rusch is the Vice President, Scientific Strategy & Commercial Development at Celerion. Dr. Rusch is a metabolism chemist by training, holding a PhD in Bioanalytical Chemistry and Laboratory Medicine. She has led IND and NDA programs at biotechnology companies as well as launched clinical pharmacology offerings in areas as diverse as human abuse liability, QTc cardiovascular safety assessment and metabolic disease offerings at leading CROs. As an experienced drug development professional, Dr. Rusch has significant preclinical and translational medicine expertise designing, overseeing and executing NDA-enabling studies with a focus on challenging areas of translational development. She provides clinical pharmacology leadership of the medical and operations clinical team for early clinical pharmacology studies evaluating the safety profiles of renally-eliminated novel drug candidates in potentially vulnerable or impaired patient populations.
Oliver Grundmann, PhD (Moderator)
Clinical Associate Professor, Director, Univ of Florida Coll of Pharmacy, Medical Chemistry
Dr. Grundmann is the Clinical Associate Professor and Director of Graduate Programs in Clinical Toxicology & Pharmaceutical Chemistry at the Coll of Pharmacy, Univ of Florida. His primary research focus is centered on natural products, specifically with CNS activity for depression, anxiety and other mood disorders. Clinical investigations into potential integrative and complementary use of natural products in a variety of best practice settings have provided him with a wide range of collaborative opportunities. Aside from his research interests, Dr. Grundmann is a staunch advocate for interdisciplinary and collaborative teaching in a connected global world allowing him to travel and frequently meet with colleagues and students from all areas of the world. In a sense, both a holistic research and teaching approach. He has been a member of ACCP, a Fellow and serves currently on the Board of Regents. As part of his ongoing research collaborations, he is familiar with the significant efforts involved in writing and publishing a scientific manuscript.
Alexander J. Prokopienko, PharmD, PhD (Moderator)
Dr. Prokopienko graduated from Albany Coll of Pharmacy with his PharmD and subsequently from the Univ of Pittsburgh with his PhD in Clinical Pharmaceutical Sciences. During his PhD, Alex was selected as a recipient of the AFPE Pre-Doctoral fellowship, NIH TL1 Post-Doctoral fellowship and NIH Clinical Research Loan Repayment Program. After completing his PhD, he joined Vertex Pharmaceuticals as a Clinical Pharmacologist.